======= LRRFIP1 ======= == Gene Information == * **Official Symbol**: LRRFIP1 * **Official Name**: LRR binding FLII interacting protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9208|9208]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q32MZ4|Q32MZ4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LRRFIP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LRRFIP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603256|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. May control smooth muscle cells proliferation following artery injury through PDGFA repression. May also bind double-stranded RNA. Positively regulates Toll-like receptor (TLR) signaling in response to agonist probably by competing with the negative FLII regulator for MYD88-binding. {ECO:0000269|PubMed:10364563, ECO:0000269|PubMed:14522076, ECO:0000269|PubMed:16199883, ECO:0000269|PubMed:19265123, ECO:0000269|PubMed:9705290}. |DUF2051| |double-stranded RNA binding| |positive regulation of type I interferon production| |regulation of type I interferon production| |positive regulation of NF-kappaB transcription factor activity| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |positive regulation of DNA-binding transcription factor activity| |cadherin binding| |cytoskeleton| |regulation of DNA-binding transcription factor activity| |positive regulation of cytokine production| |RNA polymerase II proximal promoter sequence-specific DNA binding| |regulation of cytokine production| |negative regulation of transcription by RNA polymerase II| |protein homodimerization activity| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| |positive regulation of multicellular organismal process| |positive regulation of molecular function| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-1.74| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15224 * **Expression level (log2 read counts)**: 7.64 {{:chemogenomics:nalm6 dist.png?nolink |}}